Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Launching a Comparative Effectiveness Adaptive Platform Trial of Monoclonal Antibodies for COVID-19 in 21 Days.

Erin K. McCreary,J. Ryan Bariola,Tami Minnier,Richard J. Wadas,Judith A. Shovel,Debbie Albin,Oscar C. Marroquin,Mark Schmidhofer,Mary Kay Wisniewski,David A. Nace,Colleen Sullivan,Meredith Axe,Russell Meyers,Tina Khadem,William Garrard,Kevin Collins,Alan Wells,Robert D. Bart,Kelsey Linstrum,Stephanie K. Montgomery,Ghady Haidar,Graham M. Snyder,Bryan J. McVerry,Christopher W. Seymour,Donald M. Yealy,David T. Huang,Derek C. Angus

Contemporary clinical trials（2022）

Cited 7|Views21
No score
Key words
COVID-19,SARS-CoV-2,Monoclonal antibodies,Bamlanivimab,Etesevimab,Casirivimab,Imdevimab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined